Testing effectiveness (Phase 2)Study completedNCT02542514
What this trial is testing
Study of Ibrutinib in Patients With Relapsed or Refractory Primary Central Nervous Lymphoma or Intraocular Lymphoma
Who this might be right for
Primary Central Nervous LymphomaIntraocular Lymphoma
The Lymphoma Academic Research Organisation 52